In a report issued on July 30, Joshua Schimmer from Evercore ISI maintained a Buy rating on COMPASS Pathways (CMPS
Author: Howard Kim
ChampionX (CHX) Gets a Buy Rating from Evercore ISI
Evercore ISI analyst James West maintained a Buy rating on ChampionX (CHX – Research Report) on July 30 and set
Evercore ISI Sticks to Their Hold Rating for Schneider National (SNDR)
In a report issued on July 30, Jonathan Chappell from Evercore ISI maintained a Hold rating on Schneider National (SNDR
Leerink Partners Thinks Genocea Biosciences’ Stock is Going to Recover
In a report issued on July 29, Daina Graybosch from Leerink Partners maintained a Buy rating on Genocea Biosciences (GNCA
Leerink Partners Thinks Travere Therapeutics’ Stock is Going to Recover
Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) on July 29 and
Evercore ISI Remains a Buy on US Silica Holdings (SLCA)
In a report issued on July 30, Samantha Hoh from Evercore ISI maintained a Buy rating on US Silica Holdings
Leerink Partners Believes Thermo Fisher (NYSE: TMO) Won’t Stop Here
Leerink Partners analyst Puneet Souda maintained a Buy rating on Thermo Fisher (TMO – Research Report) on July 28 and